Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference96 articles.
1. Pennington, M. W., Czerwinski, A., & Norton, R. S. (2018). Peptide therapeutics from venom: Current status and potential. Bioorganic & Medicinal Chemistry, 26, 2738–2758.
2. Ferreira, S. H. A. (1965). A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca. British Journal of Pharmacology and Chemotherapy, 24(1), 163–169.
3. Cushman, D. W., & Ondetti, M. A. (1991). History of the design of captopril and related inhibitors of angiotensin converting enzyme. Hypertension, 17(4), 589–592.
4. Fernandez, J. H., Neshich, G., & Camargo, A. C. (2004). Using bradykinin-potentiating peptide structures to develop new antihypertensive drugs. Genetics and Molecular Research, 3(4), 554–563.
5. Dendorfer, A., Wolfrum, S., & Dominiak, P. (1999). Pharmacology and cardiovascular implications of the kinin-kallikrein system. Japanese Journal of Pharmacology., 79(4), 403–426.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献